275 related articles for article (PubMed ID: 29761785)
1. Discovery and characterization of a prevalent human gut bacterial enzyme sufficient for the inactivation of a family of plant toxins.
Koppel N; Bisanz JE; Pandelia ME; Turnbaugh PJ; Balskus EP
Elife; 2018 May; 7():. PubMed ID: 29761785
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics.
Haiser HJ; Seim KL; Balskus EP; Turnbaugh PJ
Gut Microbes; 2014; 5(2):233-8. PubMed ID: 24637603
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic and structural insight into promiscuity based metabolism of cardiac drug digoxin by gut microbial enzyme.
Kumar K; Jaiswal SK; Dhoke GV; Srivastava GN; Sharma AK; Sharma VK
J Cell Biochem; 2018 Jul; 119(7):5287-5296. PubMed ID: 29274283
[TBL] [Abstract][Full Text] [Related]
4. Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta.
Haiser HJ; Gootenberg DB; Chatman K; Sirasani G; Balskus EP; Turnbaugh PJ
Science; 2013 Jul; 341(6143):295-8. PubMed ID: 23869020
[TBL] [Abstract][Full Text] [Related]
5. Intestinal microbiome and digoxin inactivation: meal plan for digoxin users?
Lu L; Wu Y; Zuo L; Luo X; Large PJ
World J Microbiol Biotechnol; 2014 Mar; 30(3):791-9. PubMed ID: 24105082
[TBL] [Abstract][Full Text] [Related]
6. A widely distributed metalloenzyme class enables gut microbial metabolism of host- and diet-derived catechols.
Maini Rekdal V; Nol Bernadino P; Luescher MU; Kiamehr S; Le C; Bisanz JE; Turnbaugh PJ; Bess EN; Balskus EP
Elife; 2020 Feb; 9():. PubMed ID: 32067637
[TBL] [Abstract][Full Text] [Related]
7. Optimization of an in vitro gut microbiome biotransformation platform with chlorogenic acid as model compound: From fecal sample to biotransformation product identification.
Mortelé O; Iturrospe E; Breynaert A; Verdickt E; Xavier BB; Lammens C; Malhotra-Kumar S; Jorens PG; Pieters L; van Nuijs ALN; Hermans N
J Pharm Biomed Anal; 2019 Oct; 175():112768. PubMed ID: 31398630
[TBL] [Abstract][Full Text] [Related]
8. Genetic basis for the cooperative bioactivation of plant lignans by Eggerthella lenta and other human gut bacteria.
Bess EN; Bisanz JE; Yarza F; Bustion A; Rich BE; Li X; Kitamura S; Waligurski E; Ang QY; Alba DL; Spanogiannopoulos P; Nayfach S; Koliwad SK; Wolan DW; Franke AA; Turnbaugh PJ
Nat Microbiol; 2020 Jan; 5(1):56-66. PubMed ID: 31686027
[TBL] [Abstract][Full Text] [Related]
9. Xenobiotic Metabolism and Gut Microbiomes.
Das A; Srinivasan M; Ghosh TS; Mande SS
PLoS One; 2016; 11(10):e0163099. PubMed ID: 27695034
[TBL] [Abstract][Full Text] [Related]
10. Chemical reaction vector embeddings: towards predicting drug metabolism in the human gut microbiome.
Mallory EK; Acharya A; Rensi SE; Turnbaugh PJ; Bright RA; Altman RB
Pac Symp Biocomput; 2018; 23():56-67. PubMed ID: 29218869
[TBL] [Abstract][Full Text] [Related]
11. Chemical transformation of xenobiotics by the human gut microbiota.
Koppel N; Maini Rekdal V; Balskus EP
Science; 2017 Jun; 356(6344):. PubMed ID: 28642381
[TBL] [Abstract][Full Text] [Related]
12. GutBug: A Tool for Prediction of Human Gut Bacteria Mediated Biotransformation of Biotic and Xenobiotic Molecules Using Machine Learning.
Malwe AS; Srivastava GN; Sharma VK
J Mol Biol; 2023 Jul; 435(14):168056. PubMed ID: 37356904
[TBL] [Abstract][Full Text] [Related]
13. A novel approach for the prediction of species-specific biotransformation of xenobiotic/drug molecules by the human gut microbiota.
Sharma AK; Jaiswal SK; Chaudhary N; Sharma VK
Sci Rep; 2017 Aug; 7(1):9751. PubMed ID: 28852076
[TBL] [Abstract][Full Text] [Related]
14. Discovery of an ene-reductase for initiating flavone and flavonol catabolism in gut bacteria.
Yang G; Hong S; Yang P; Sun Y; Wang Y; Zhang P; Jiang W; Gu Y
Nat Commun; 2021 Feb; 12(1):790. PubMed ID: 33542233
[TBL] [Abstract][Full Text] [Related]
15. Anaerobic 4-hydroxyproline utilization: Discovery of a new glycyl radical enzyme in the human gut microbiome uncovers a widespread microbial metabolic activity.
Huang YY; Martínez-Del Campo A; Balskus EP
Gut Microbes; 2018; 9(5):437-451. PubMed ID: 29405826
[TBL] [Abstract][Full Text] [Related]
16. The role of gut microbiota in fetal methylmercury exposure: Insights from a pilot study.
Rothenberg SE; Keiser S; Ajami NJ; Wong MC; Gesell J; Petrosino JF; Johs A
Toxicol Lett; 2016 Feb; 242():60-67. PubMed ID: 26626101
[TBL] [Abstract][Full Text] [Related]
17. The Gut Microbiota Impact Cancer Etiology through "Phase IV Metabolism" of Xenobiotics and Endobiotics.
Ervin SM; Redinbo MR
Cancer Prev Res (Phila); 2020 Aug; 13(8):635-642. PubMed ID: 32611614
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of hydrogen gases and bile acids in the gut microbiome.
Hylemon PB; Harris SC; Ridlon JM
FEBS Lett; 2018 Jun; 592(12):2070-2082. PubMed ID: 29683480
[TBL] [Abstract][Full Text] [Related]
19. Drug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry?
Swanson HI
Drug Metab Dispos; 2015 Oct; 43(10):1499-504. PubMed ID: 26261284
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of digoxin by Eubacterium lentum, an anaerobe of the human gut flora.
Dobkin JF; Saha JR; Butler VP; Neu HC; Lindenbaum J
Trans Assoc Am Physicians; 1982; 95():22-9. PubMed ID: 7182977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
